ES2193146T3 - Composicion farmaceutica con inicio de liberacion y velocidad de liberacion controlados. - Google Patents

Composicion farmaceutica con inicio de liberacion y velocidad de liberacion controlados.

Info

Publication number
ES2193146T3
ES2193146T3 ES94113304T ES94113304T ES2193146T3 ES 2193146 T3 ES2193146 T3 ES 2193146T3 ES 94113304 T ES94113304 T ES 94113304T ES 94113304 T ES94113304 T ES 94113304T ES 2193146 T3 ES2193146 T3 ES 2193146T3
Authority
ES
Spain
Prior art keywords
release
pharmaceutical composition
controlled
speed
beginning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94113304T
Other languages
English (en)
Inventor
Minoru Okada
Kenji Ono
Shuichi Kasai
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2193146T3 publication Critical patent/ES2193146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA CON UNA INICIACION DE LA LIBERACION CONTROLADA Y UNA VELOCIDAD DE LA LIBERACION CONTROLADA EN QUE UNA COMPOSICION QUE CONTIENE UN FARMACO SE REVISTE CON UNA CAPA DE MEMBRANA QUE CONTIENE UN POLIMERO ALTO INSOLUBLE EN AGUA Y SILICONA. EL TIEMPO DE INICIO DE LA LIBERACION DE LOS FARMACOS DE LA COMPOSICION FARMACEUTICA CON UNA INICIACION DE LA LIBERACION CONTROLADA Y UNA VELOCIDAD DE LIBERACION CONTROLADA DE ESTE INVENCION Y LA VELOCIDAD DE LIBERACION DEL FARMACO POSTERIOR SE PUEDEN CONTROLAR SEGUN SE DESEE.
ES94113304T 1993-08-25 1994-08-25 Composicion farmaceutica con inicio de liberacion y velocidad de liberacion controlados. Expired - Lifetime ES2193146T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5210453A JP2916978B2 (ja) 1993-08-25 1993-08-25 放出開始制御型製剤

Publications (1)

Publication Number Publication Date
ES2193146T3 true ES2193146T3 (es) 2003-11-01

Family

ID=16589589

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94113304T Expired - Lifetime ES2193146T3 (es) 1993-08-25 1994-08-25 Composicion farmaceutica con inicio de liberacion y velocidad de liberacion controlados.

Country Status (9)

Country Link
US (1) US5496561A (es)
EP (1) EP0640337B1 (es)
JP (1) JP2916978B2 (es)
KR (1) KR100280099B1 (es)
CN (1) CN1112919C (es)
CA (1) CA2130595A1 (es)
DE (1) DE69432618T2 (es)
ES (1) ES2193146T3 (es)
TW (1) TW420618B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US20060068018A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
DE19758100B4 (de) 1997-12-18 2006-05-04 Lichtwer Pharma Ag Verfahren zum Herstellen von Pflanzenextrakt enthaltenden pharmazeutischen Formulierungen
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
AU2004200325B2 (en) * 1998-10-21 2006-09-28 Shire Llc Oral Pulsed Dose Drug Delivery System
DK1126826T6 (en) * 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
WO2001015668A1 (en) 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release pellet formulation
BR0016555A (pt) 1999-12-23 2002-09-17 Pfizer Prod Inc Composições farmacêuticas que proporcionam concentrações acrescidas de droga
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US7968119B2 (en) * 2001-06-26 2011-06-28 Farrell John J Tamper-proof narcotic delivery system
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US6913768B2 (en) * 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
US20050031688A1 (en) * 2003-08-04 2005-02-10 Ayala William J. Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
NZ555842A (en) * 2004-12-09 2010-10-29 Celgene Corp Treatment of various conditions of patients with Tourette syndrome, tics, or a family history thereof sing D-threo methylphenidate free from other isomers
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US8846100B2 (en) 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
US20080241240A1 (en) * 2006-08-24 2008-10-02 Hanall Pharmaceutical Co., Ltd. Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
JP2009191036A (ja) * 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
SI3121280T1 (sl) * 2008-11-13 2025-08-29 Nogra Pharma Limited Antismiselne sestave in postopki za njihovo izdelavo ter uporabo
EP2531181B1 (en) * 2010-02-03 2019-04-10 Pharma Two B Ltd. Extended release formulations of rasagiline and uses thereof
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
MX2021000431A (es) 2011-03-23 2022-10-28 Ironshore Pharmaceuticals & Dev Inc Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
JP5836980B2 (ja) 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
CN110170027B (zh) * 2019-04-23 2021-06-29 广东健信制药股份有限公司 一种山楂红曲粉丸剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US4894231A (en) * 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
JP2892858B2 (ja) * 1991-05-15 1999-05-17 田辺製薬株式会社 放出制御製剤およびその製造法
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
JP3142919B2 (ja) * 1991-11-06 2001-03-07 旭化成株式会社 セルロース誘導体ラテックス及びその製法
CA2122479C (en) * 1991-11-22 1998-08-25 Richard John Dansereau Risedronate delayed-release compositions

Also Published As

Publication number Publication date
US5496561A (en) 1996-03-05
JPH0761922A (ja) 1995-03-07
EP0640337B1 (en) 2003-05-07
JP2916978B2 (ja) 1999-07-05
KR950005301A (ko) 1995-03-20
EP0640337A2 (en) 1995-03-01
CN1109743A (zh) 1995-10-11
DE69432618T2 (de) 2004-02-19
KR100280099B1 (ko) 2001-02-01
CA2130595A1 (en) 1995-02-26
EP0640337A3 (en) 1999-05-12
DE69432618D1 (de) 2003-06-12
CN1112919C (zh) 2003-07-02
TW420618B (en) 2001-02-01

Similar Documents

Publication Publication Date Title
ES2193146T3 (es) Composicion farmaceutica con inicio de liberacion y velocidad de liberacion controlados.
ES2070252T3 (es) Composicion de resina de polipropileno resistente a la radiacion.
ES2141713T3 (es) Formulaciones estabilizadas de liberacion controlada recubiertas de una capa de polimero acrilico.
ES2146589T3 (es) Preparacion medicamentosa para jeringa.
ES2059729T3 (es) Preparado farmaceutico de liberacion controlada y metodo para producir el mismo.
ES2072275T3 (es) Composiciones que constan de copolimeros de polifenilen eter-poliester a partir de polifenilen eteres terminados en epoxitriazina.
CY1107592T1 (el) Υπογλωσσιο στοματικο αναβραζον μεσο
ES2163565T3 (es) Pelicula soplada que comprende almidon desestructurado y un polimero termoplastico.
SE7402773L (es)
ES2091363T3 (es) Compuesto farmaceutico de liberacion controlada con propiedades bioadhesivas.
ES2132162T3 (es) Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo.
ES2045069T3 (es) Pelicula polimerica silenciosa y recipientes para uso medico con ella fabricados.
ES2116606T3 (es) Recubrimientos de superficie polimericos.
NO985964D0 (no) Administrasjonskur for H+, K+ -ATPase-inhibitorer
DE3869520D1 (en) Transdermales therapeutisches system.
CO5150239A1 (es) Implantes medicinales recubiertos con polimeros o una mezcla de polimeros, solucion esteril que contiene tales polimeros y empleo de los mismos, y procedimiento para la preparacion de estos implantes medicinales
TR199501216A2 (tr) Belirli bir izomer dagilimina sahip siklik ya da polisiklik monomerleri iceren kopolimerler, ve bunlarin boya kompozisyonlarinda kullanimi.
ES2056820T3 (es) Composiciones adhesivas modificadas por acido.
ES2070854T3 (es) Composiciones polimericas.
ES2084877T3 (es) Procedimiento para la obtencion de diacetilreina.
ES2072272T3 (es) Composicion polimera curable.
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
ES2046889T3 (es) Metodo para inhibicion de la maduracion folicular.
ES2174458T3 (es) Composiciones filmogenas.
JPS51129438A (en) Adhesive composition